Research Paper Volume 13, Issue 17 pp 21283—21293

RUFY3 promotes the progression of hepatocellular carcinoma through activating NF-κB-mediated epithelial-mesenchymal transition

Expression levels of RUFY3 in HCC tissues. (A) Detection of RUFY3 mRNA expression in HCC tissues and adjacent normal tissues by qRT-PCR. (B) Detection of RUFY3 protein expression in HCC cancer tissues (C) and matched normal tissues (N) by western blot analysis. (C) Detection of RUFY3 expression in HCC tissues and matched normal tissues by IHC analysis. (D) Quantitative analysis of RUFY3 expression in HCC tissues and adjacent normal tissues according to IHC staining scores. (E) Kaplan-Meier analysis of overall survival for HCC patients with different levels of RUFY3 expression. *P

Figure 1. Expression levels of RUFY3 in HCC tissues. (A) Detection of RUFY3 mRNA expression in HCC tissues and adjacent normal tissues by qRT-PCR. (B) Detection of RUFY3 protein expression in HCC cancer tissues (C) and matched normal tissues (N) by western blot analysis. (C) Detection of RUFY3 expression in HCC tissues and matched normal tissues by IHC analysis. (D) Quantitative analysis of RUFY3 expression in HCC tissues and adjacent normal tissues according to IHC staining scores. (E) Kaplan-Meier analysis of overall survival for HCC patients with different levels of RUFY3 expression. *P<0.05.